Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Obeticholic Acid Market Size, Value And Growth Trajectory Through 2030
The obeticholic acid market size has seen significant expansion in recent years. It is anticipated to increase from $1.01 billion in 2025 to $1.14 billion in 2026, at a compound annual growth rate (CAGR) of 12.9%. The growth witnessed in prior periods can be attributed to factors such as clinical approval for primary biliary cholangitis treatment, a rise in liver disease diagnoses, the proliferation of hepatology clinics, heightened awareness regarding bile acid regulation therapies, and an increase in specialty liver drugs.
The obeticholic acid market is anticipated to experience significant expansion over the coming years. This market is projected to reach a value of $1.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. Key drivers for this growth during the forecast period include a rising NASH patient demographic, the broadening of liver disease drug development pipelines, enhanced uptake of diagnostic screening methods, increased funding for hepatology research, and the worldwide proliferation of oral liver treatments. Noteworthy trends anticipated during the same period encompass the growing incidence of chronic liver conditions, greater acceptance of FXR agonist treatments, an intensified emphasis on liver drugs that modify disease progression, the widening scope of nonalcoholic steatohepatitis investigations, and the increased application of oral hepatology interventions.
Get A Free Sample Report With In-Depth Market Insights:
Obeticholic Acid Market Demand Drivers Opening New Revenue Streams
The increasing incidence of liver ailments is anticipated to drive the expansion of the obeticholic acid market moving ahead. Liver diseases are conditions that impair the liver’s ability to function properly. This surge in liver diseases stems from excessive alcohol consumption, which damages liver cells and compromises the organ’s proper operation, potentially resulting in liver inflammation, cirrhosis, and liver failure. Obeticholic acid aids individuals with liver disease by stimulating the farnesoid X receptor (FXR), thereby decreasing bile acid accumulation, mitigating liver inflammation, and retarding the advancement of fibrosis, leading to enhanced liver function. As an illustration, the Office for Health Improvement and Disparities, a UK-based government department, stated in December 2024 that premature deaths from alcoholic liver disease rose by 3.6% in 2023, totaling 5,984, an increase from 5,776 in 2022. Consequently, the growing occurrence of liver diseases is fueling the development of the obeticholic acid market.
Obeticholic Acid Market Segment Trends And Revenue Contributors
The obeticholic acid market covered in this report is segmented –
1) By Product Type: Immediate-Release Tablets, Modified-Release Tablets, Film-Coated Tablets
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Other Applications
Subsegments:
1) By Immediate-Release Tablets: Standard Oral Tablets, Low-Dose Strength Tablets
2) By Modified-Release Tablets: Controlled Exposure Tablets, Once-Daily Optimized Release Tablets
3) By Film-Coated Tablets: Taste-Masked Tablets, Gastrointestinal-Tolerant Tablets
Obeticholic Acid Market Trends Powering Strategic Industry Growth
Major companies active in the obeticholic acid market are engaged in creating innovative products, including farnesoid X receptor (FXR) agonists, to enhance liver disease treatment and improve patient outcomes. A farnesoid X receptor (FXR) agonist is a compound that activates the FXR, which is a nuclear receptor instrumental in regulating bile acid metabolism, inflammation, and fibrosis in the liver. Farnesoid X receptor (FXR) agonists contribute to better liver function and are employed in addressing conditions such as primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). For example, in February 2024, Intercept Pharmaceuticals Inc., a US-based biopharmaceutical company, disclosed that the U.S. Food and Drug Administration (FDA) had accepted its supplemental New Drug Application (sNDA) for Ocaliva, aimed at treating individuals with primary biliary cholangitis (PBC). The FDA’s acceptance of the supplemental New Drug Application (sNDA) for obeticholic acid (Ocaliva) signifies notable regulatory progress in validating its clinical benefits for PBC treatment.
Obeticholic Acid Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the obeticholic acid market are Intercept Pharmaceuticals Inc., Genfit, Gilead Sciences Inc., Pfizer Inc., Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.
View The Full Obeticholic Acid Market Report:
Obeticholic Acid Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the Obeticholic Acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the obeticholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
